Earnings Ahead

WBA - Walgreens Boots Alliance Inc

25.84 -0.81 -3.04

Walgreens Boots Alliance Inc

Walgreens Boots Alliance Inc

About

Profile

Walgreens Boots Alliance (Nasdaq: WBA) is the first global pharmacy-led, health and wellbeing enterprise.


Headquarters

Deerfield, Illinois, United States


Intraday

High
-
Low
-

52-week

High
-
Low
-

WBA

The pharmacy stock surged 11% on better-than-expected results in the fiscal first quarter. Walgreens reported 51 cents adjusted earnings per share on $39.46 billion in revenue. Analysts surveyed by LSEG had forecasted earnings of 37 cents per share and $37.36 billion in revenue. Meanwhile, the company maintained its fiscal 2025 adjusted earnings guidance range between $1.40 and $1.80 per share.


 
...

Available for logged in users only.



The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.
  • Walgreens Boots Alliance in charts: Y/Y sales grow across all segments in Q4
  • Walgreens trails consensus in FY24 earnings outlook
  • Walgreens Boots Alliance Non-GAAP EPS of $0.67 misses by $0.02, revenue of $35.42B beats by $580M
  • Most crowded longs and shorts going into earnings season
  • Eyes on profitability during Walgreens Q4 earnings
  • Walgreens names ex-Cigna executive Tim Wentworth as new CEO
  • Catalyst Watch: Eyes on the Birkenstock IPO, PepsiCo earnings and FOMC minutes
  • Berenberg: Get defensive with healthcare, utilities and telecoms
  • Walgreens CIO leaves; former Express Scripts CIO hired as consultant: report
  • Biggest stock movers today: Walgreens Boots Alliance, Nike, Editas Medicine and more
  • Walgreens reportedly eyeing ex-Cigna executive for CEO role
  • Updated COVID boosters to divide America
  • GoodRx, drug discount cards impacting pharmacy margins - BoA
  • P&G, Kenvue, Walgreens face class action suit over cold medicine drug
  • CVS Health, Walgreens hit with FDA warning letter
  • Walgreens in pact to advance value-based care
  • Walmart considering buying majority stake in ChenMed - report
  • Walgreens in $44M settlement over Theranos fraud claims
  • Walgreens Boots CEO Rosalind Brewer resigns
  • Emergent to launch over-the-counter opioid overdose therapy in September
PEERS

Earnings History

Date EPS / Forecast Revenue / Forecast
January 6, 2022 1.68 / 1.35 33.9B / 32.46B Beat!
October 14, 2021 1.17 / 1.04 34.26B / 33.03B Beat!
July 1, 2021 1.38 / 1.16 34.03B / 33.49B Beat!
March 31, 2021 1.4 / 1.1 32.78B / 36.2B
January 7, 2021 1.22 / 1.03 36.31B / 34.93B Beat!
October 15, 2020 1.02 / 0.9609 34.75B / 34.37B Beat!
July 9, 2020 0.83 / 1.19 34.63B / 34.3B Beat!
April 2, 2020 1.52 / 1.46 35.82B / 35.27B Beat!
January 8, 2020 1.37 / 1.41 34.34B / 34.58B
October 28, 2019 1.43 / 1.41 33.95B / 33.88B Beat!
June 27, 2019 1.47 / 1.43 34.59B / 34.44B Beat!
April 2, 2019 1.64 / 1.72 34.53B / 34.58B
December 20, 2018 1.46 / 1.43 33.79B / 33.86B
October 11, 2018 1.48 / 1.45 33.44B / 33.84B
June 28, 2018 1.53 / 1.48 34.33B / 34.1B Beat!
March 28, 2018 1.73 / 1.55 33.02B / 32.2B Beat!
October 4, 2017 1.31 / 1.21 30.15B / 29,942M
June 29, 2017 1.07 / 1.30 30.12B / 29,757M Beat!
Date Price Open High Low Vol Change
Jan 29 11.25 10.88
11.42
10.87
16.9M 3.31%
Jan 28 10.89 11.27
11.32
10.7
19.0M -3.97%
Jan 27 11.34 11.98
12.13
10.66
36.5M -4.47%
Jan 24 11.87 11.65
11.87
11.56
13.0M 1.11%
Jan 23 11.74 11.61
12.09
11.48
17.7M 1.03%
 
Jan 22 11.62 11.25
11.64
11.13
20.2M 2.20%
Jan 21 11.37 11.72
11.74
10.77
50.9M -9.19%
Jan 17 12.52 13.03
13.25
12.43
35.0M -3.17%
Jan 16 12.93 12.4
12.97
12.31
18.8M 3.19%
Jan 15 12.53 12.46
12.57
12.02
24.1M 2.37%
Jan 14 12.24 11.93
12.35
11.74
33.2M 2.86%
Jan 13 11.9 11.65
11.94
10.96
36.3M 1.19%
Jan 10 11.76 10.6
12
10.5
104M 27.55%
Jan 8 9.22 9.5
9.55
9.2
22.1M -4.65%
Jan 7 9.67 9.58
10.1
9.55
20.4M 2.11%
Jan 6 9.47 9.6
9.97
9.41
21.1M -0.32%
Jan 3 9.5 9.2
9.52
9.13
14.3M 3.37%
Jan 2 9.19 9.39
9.59
9.07
17.5M -1.5%
Dec 31, 2024 9.33 9.3
9.51
9.22
12.6M 0.76%
Dec 30, 2024 9.26 9.48
9.53
9.23
14.0M -3.74%
Dec 27, 2024 9.62 9.6
9.73
9.54
11.6M -0.62%
Dec 26, 2024 9.68 9.15
9.7
9.14
15.7M 5.33%
Dec 24, 2024 9.19 9.26
9.29
9.12
8.7M -1.18%
Dec 23, 2024 9.3 9.49
9.54
9.19
18.5M -2.62%
Dec 20, 2024 9.55 9.35
9.61
9.28
30.0M 2.14%
Dec 19, 2024 9.35 9.61
9.77
9.3
19.4M -3.61%
Dec 18, 2024 9.7 9.89
10.15
9.63
25.8M -2.71%
Dec 17, 2024 9.97 10.04
10.39
9.54
31.0M -2.06%
Dec 16, 2024 10.18 10.2
10.2
9.85
26.2M -2.02%
Dec 13, 2024 10.39 9.65
10.45
9.41
38.9M 6.78%
Dec 12, 2024 9.73 9.84
10.02
9.56
20.1M -1.12%
Dec 11, 2024 9.84 9.96
10.37
9.54
44.7M -5.57%
Dec 10, 2024 10.42 8.85
11.3
8.54
105M 17.74%
Dec 9, 2024 8.85 8.65
9.11
8.56
22.2M 3.39%
Dec 6, 2024 8.56 8.65
8.82
8.46
15.9M 1.06%
Dec 5, 2024 8.47 8.79
8.87
8.35
24.9M -3.09%
Dec 4, 2024 8.74 8.95
9.1
8.73
14.4M -2.35%
Dec 3, 2024 8.95 9.02
9.06
8.79
14.9M -0.33%
Dec 2, 2024 8.98 9
9.07
8.87
18.7M -0.44%
Nov 29, 2024 9.02 9.08
9.19
8.98
10.1M -0.44%
Nov 27, 2024 9.06 8.77
9.08
8.77
13.8M 3.78%
Nov 26, 2024 8.73 8.95
8.97
8.65
17.4M -3.64%
Nov 25, 2024 9.06 8.73
9.15
8.69
29.6M 4.62%
Nov 22, 2024 8.66 8.33
8.69
8.21
20.1M 4.34%
Nov 21, 2024 8.3 8.26
8.33
8.08
19.3M 0.73%
Nov 20, 2024 8.24 8.24
8.33
8.11
25.8M -0.6%
Nov 19, 2024 8.29 8.52
8.68
8.25
22.5M -4.27%
Nov 18, 2024 8.66 8.25
8.95
8.2
25.3M 2.12%
Nov 15, 2024 8.48 8.89
8.9
8.46
22.2M -3.75%
Nov 14, 2024 8.81 9.09
9.12
8.74
19.6M -2.44%
Nov 13, 2024 9.03 9.03
9.25
8.98
16.8M 0.22%
Nov 12, 2024 9.01 9.25
9.38
8.91
22.4M -4.05%
Nov 11, 2024 9.39 9.15
9.56
9.03
20.4M 3.53%
Nov 8, 2024 9.07 9.25
9.39
9.05
21.1M -2.16%
Nov 7, 2024 9.27 9.38
9.59
9.25
19.2M 0.43%
Nov 6, 2024 9.23 9.83
9.85
9.21
21.7M -4.05%
Nov 5, 2024 9.62 9.29
9.62
9.17
18.3M 3.11%
Nov 4, 2024 9.33 9.51
9.69
9.31
12.3M -1.37%
Nov 1, 2024 9.46 9.56
9.57
9.35
12.2M 0%
Oct 31, 2024 9.46 9.24
9.5
9.08
17.1M 0%